Journal article
Appropriate medical management of chronic rhinosinusitis reduces use of antibiotics and oral corticosteroids.
- Speth MM Klinik für Hals-, Nasen-, Ohren- Krankheiten, Hals-und Gesichtschirurgie, Kantonsspital Aarau, Switzerland.
- Phillips KM Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, California, U.S.A.
- Hoehle LP Edward Via College of Osteopathic Medicine-Carolinas, Spartanburg, South Carolina, U.S.A.
- Caradonna DS Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts, U.S.A.
- Gray ST Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts, U.S.A.
- Sedaghat AR Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, U.S.A.
- 2019-12-18
Published in:
- The Laryngoscope. - 2020
English
OBJECTIVES/HYPOTHESIS
Antibiotics and oral corticosteroids are used in the treatment of acute exacerbations of chronic rhinosinusitis (AECRS) and reflect poor disease control. We sought to characterize utilization of these systemic medications after appropriate medical management of chronic rhinosinusitis (CRS).
STUDY DESIGN
Prospective observational study.
METHODS
One hundred fifty patients undergoing medical management for CRS were studied. Data were collected at enrollment and follow-up 3 to 12 months later. All patients were asked to report the number of CRS-related antibiotics and oral corticosteroids used in the last 3 months. CRS symptom burden was measured using the 22-item Sino-Nasal Outcome Test (SNOT-22). Associations were sought between CRS-related antibiotics and oral corticosteroids use at follow-up compared to enrollment.
RESULTS
From enrollment to follow-up, the mean number of CRS-related antibiotics courses used decreased by 0.2 courses (95% confidence interval [CI]: 0.1-0.4, P = .012), and the mean number of CRS-related oral corticosteroid courses used also decreased by 0.2 courses (95% CI: 0.1-0.3, P = .029). The number of CRS-related antibiotics used at follow-up was associated with CRS-related antibiotic use at enrollment (adjusted rate ratio [RR] = 1.58, 95% CI: 1.17-2.13, P = .003). The number of CRS-related oral corticosteroids used at follow-up was associated with reported CRS-related oral corticosteroid use at enrollment (adjusted RR = 3.20, 95% CI: 1.69-6.07, P < .001). SNOT-22 results at enrollment were also not predictive of future systemic medication use.
CONCLUSIONS
Appropriate medical management of CRS is associated with decreased use of oral antibiotics and corticosteroids. Previous utilization of antibiotics and oral corticosteroids for CRS is associated with future use of these medications.
LEVEL OF EVIDENCE
2c Laryngoscope, 2019.
Antibiotics and oral corticosteroids are used in the treatment of acute exacerbations of chronic rhinosinusitis (AECRS) and reflect poor disease control. We sought to characterize utilization of these systemic medications after appropriate medical management of chronic rhinosinusitis (CRS).
STUDY DESIGN
Prospective observational study.
METHODS
One hundred fifty patients undergoing medical management for CRS were studied. Data were collected at enrollment and follow-up 3 to 12 months later. All patients were asked to report the number of CRS-related antibiotics and oral corticosteroids used in the last 3 months. CRS symptom burden was measured using the 22-item Sino-Nasal Outcome Test (SNOT-22). Associations were sought between CRS-related antibiotics and oral corticosteroids use at follow-up compared to enrollment.
RESULTS
From enrollment to follow-up, the mean number of CRS-related antibiotics courses used decreased by 0.2 courses (95% confidence interval [CI]: 0.1-0.4, P = .012), and the mean number of CRS-related oral corticosteroid courses used also decreased by 0.2 courses (95% CI: 0.1-0.3, P = .029). The number of CRS-related antibiotics used at follow-up was associated with CRS-related antibiotic use at enrollment (adjusted rate ratio [RR] = 1.58, 95% CI: 1.17-2.13, P = .003). The number of CRS-related oral corticosteroids used at follow-up was associated with reported CRS-related oral corticosteroid use at enrollment (adjusted RR = 3.20, 95% CI: 1.69-6.07, P < .001). SNOT-22 results at enrollment were also not predictive of future systemic medication use.
CONCLUSIONS
Appropriate medical management of CRS is associated with decreased use of oral antibiotics and corticosteroids. Previous utilization of antibiotics and oral corticosteroids for CRS is associated with future use of these medications.
LEVEL OF EVIDENCE
2c Laryngoscope, 2019.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1002/lary.28390
- PMID 31846092
- Persistent URL
- https://sonar.ch/global/documents/93336
Statistics
Document views: 23
File downloads: